{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:00:18Z","timestamp":1780498818381,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00198-025-07811-8","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T11:37:08Z","timestamp":1766403428000},"page":"435-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A programmatic approach to osteoporosis treatment: insight from a 20-year longitudinal study"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2324-8762","authenticated-orcid":false,"given":"Lillian","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Chukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Olenginski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idorenyin","family":"Udoeyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonida","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"7811_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882241","volume":"13","author":"Y Shen","year":"2022","unstructured":"Shen Y, Huang X, Wu J et al (2022) The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990-2019. Front Endocrinol (Lausanne) 13:882241. https:\/\/doi.org\/10.3389\/fendo.2022.882241","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"7811_CR2","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s00198-015-3154-6","volume":"26","author":"A Od\u00e9n","year":"2015","unstructured":"Od\u00e9n A, McCloskey EV, Kanis JA, Harvey NC, Johansson H (2015) Burden of high fracture probability worldwide: secular increases 2010\u20132040. Osteoporos Int 26(9):2243\u20132248. https:\/\/doi.org\/10.1007\/s00198-015-3154-6","journal-title":"Osteoporos Int"},{"issue":"11","key":"7811_CR3","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/jbmr.2269","volume":"29","author":"NC Wright","year":"2014","unstructured":"Wright NC, Looker AC, Saag KG et al (2014) The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 29(11):2520\u20132526. https:\/\/doi.org\/10.1002\/jbmr.2269","journal-title":"J Bone Miner Res"},{"issue":"1","key":"7811_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mayocp.2014.09.011","volume":"90","author":"A Singer","year":"2015","unstructured":"Singer A, Exuzides A, Spangler L et al (2015) Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. Mayo Clin Proc 90(1):53\u201362. https:\/\/doi.org\/10.1016\/j.mayocp.2014.09.011","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"7811_CR5","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.injury.2008.03.022","volume":"39","author":"S Haleem","year":"2008","unstructured":"Haleem S, Lutchman L, Mayahi R, Grice JE, Parker MJ (2008) Mortality following hip fracture: trends and geographical variations over the last 40 years. Injury 39(10):1157\u20131163. https:\/\/doi.org\/10.1016\/j.injury.2008.03.022","journal-title":"Injury"},{"issue":"9","key":"7811_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10192","volume":"3","author":"EM Lewiecki","year":"2019","unstructured":"Lewiecki EM, Ortendahl JD, Vanderpuye-Orgle J et al (2019) Healthcare policy changes in osteoporosis can improve outcomes and reduce costs in the United States. JBMR Plus 3(9):e10192. https:\/\/doi.org\/10.1002\/jbm4.10192","journal-title":"JBMR Plus"},{"issue":"9","key":"7811_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/jbmr.2202","volume":"29","author":"DH Solomon","year":"2014","unstructured":"Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29(9):1929\u20131937. https:\/\/doi.org\/10.1002\/jbmr.2202","journal-title":"J Bone Miner Res"},{"issue":"3","key":"7811_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0826","volume":"1","author":"RJ Desai","year":"2018","unstructured":"Desai RJ, Mahesri M, Abdia Y et al (2018) Association of osteoporosis medication use after hip fracture with prevention of subsequent nonvertebral fractures: an instrumental variable analysis. JAMA Netw Open 1(3):e180826. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0826","journal-title":"JAMA Netw Open"},{"issue":"2","key":"7811_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00198-014-2967-z","volume":"26","author":"TP Olenginski","year":"2015","unstructured":"Olenginski TP, Maloney-Saxon G, Matzko CK et al (2015) High-risk osteoporosis clinic (HiROC): improving osteoporosis and post fracture care with an organized, programmatic approach. Osteoporos Int 26(2):801\u2013810. https:\/\/doi.org\/10.1007\/s00198-014-2967-z","journal-title":"Osteoporos Int"},{"key":"7811_CR10","doi-asserted-by":"publisher","unstructured":"Olenginski Thomas P (2023) Geisinger high-risk osteoporosis clinic: narrowing post-fracture care gaps and lessons learned.\u00a0Med Res Arch [S.l.], 11(1). ISSN 2375\u20131924.\u00a0 https:\/\/doi.org\/10.18103\/mra.v11i1.3481","DOI":"10.18103\/mra.v11i1.3481"},{"key":"7811_CR11","doi-asserted-by":"publisher","unstructured":"Ross BJ, Lee OC, Harris MB, Dowd TC, Savoie FH 3rd, Sherman WF (2021) Rates of Osteoporosis Management and Secondary Preventative Treatment After Primary Fragility Fractures. JB JS Open Access. 2021 Jun 14;6(2):e20.00142. https:\/\/doi.org\/10.2106\/JBJS.OA.20.00142","DOI":"10.2106\/JBJS.OA.20.00142"},{"issue":"3","key":"7811_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.spinee.2018.08.004","volume":"19","author":"DW Barton","year":"2019","unstructured":"Barton DW, Behrend CJ, Carmouche JJ (2019) Rates of osteoporosis screening and treatment following vertebral fracture. Spine J 19(3):411\u2013417","journal-title":"Spine J"},{"key":"7811_CR13","doi-asserted-by":"publisher","unstructured":"Khosla S, Hofbauer L (2018) Osteoporosis: a roadmap to close the treatment gap. Lancet Diabetes Endocrinol 6(11):833. ISSN 2213\u20138587. https:\/\/doi.org\/10.1016\/S2213-8587(18)30292-4","DOI":"10.1016\/S2213-8587(18)30292-4"},{"key":"7811_CR14","doi-asserted-by":"publisher","unstructured":"Malik AT, Gordon A, Awan H, Khan SN, Goyal KS (2024) Declining trend in anti-osteoporotic treatment, despite a rise in DEXA screening following \u201cSentinel\u201d distal radius fractures. Hand (N Y) 19(6):978\u2013985. https:\/\/doi.org\/10.1177\/15589447231153176","DOI":"10.1177\/15589447231153176"},{"issue":"1","key":"7811_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11657-016-0285-0","volume":"11","author":"AA Yusuf","year":"2016","unstructured":"Yusuf AA, Matlon TJ, Grauer A, Barron R, Chandler D, Peng Y (2016) Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries. Arch Osteoporos 11(1):31. https:\/\/doi.org\/10.1007\/s11657-016-0285-0","journal-title":"Arch Osteoporos"},{"issue":"3 Suppl","key":"7811_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/OI9.0000000000000184","volume":"5","author":"TM Hoggard","year":"2022","unstructured":"Hoggard TM, Jeray KJ (2022) Osteoporosis management in the United States. OTA Int 5(3 Suppl):e184. https:\/\/doi.org\/10.1097\/OI9.0000000000000184","journal-title":"OTA Int"},{"issue":"7","key":"7811_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.18553\/jmcp.2017.23.7.735","volume":"23","author":"J Weaver","year":"2017","unstructured":"Weaver J, Sajjan S, Lewiecki EM, Harris ST (2017) Diagnosis and treatment of osteoporosis before and after fracture: a side-by-side analysis of commercially insured and Medicare Advantage osteoporosis patients. J Manag Care Spec Pharm 23(7):735\u2013744. https:\/\/doi.org\/10.18553\/jmcp.2017.23.7.735","journal-title":"J Manag Care Spec Pharm"},{"key":"7811_CR18","doi-asserted-by":"publisher","unstructured":"Cauley JA, Nelson DA (2021) Chapter 19 - Race, ethnicity, and osteoporosis. Marcus and Feldman\u2019s Osteoporosis (Fifth Edition). 1:453\u2013475. ISBN 9780128130735. https:\/\/doi.org\/10.1016\/B978-0-12-813073-5.00019-8","DOI":"10.1016\/B978-0-12-813073-5.00019-8"},{"key":"7811_CR19","doi-asserted-by":"publisher","unstructured":"Noel SE, Santos MP, Wright NC (2021) Racial and ethnic disparities in bone health and outcomes in the United States. J Bone Miner Res 36(10):1881\u20131905. https:\/\/doi.org\/10.1002\/jbmr.4417","DOI":"10.1002\/jbmr.4417"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07811-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07811-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07811-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:07:02Z","timestamp":1772582822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07811-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7811"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07811-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}